Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 January 2020 | Story Igno van Niekerk | Photo Igno van Niekerk
Success is tied to the company you keep
Prof Brownhilder Neneh believes failure is part of success – it teaches you to be persistent and resilient.

As a young girl growing up in the Cameroon, her dad told her that once she had completed her first degree, she could choose where in the world she wanted to study. Her first choice was the United States; she applied and was admitted.

So, how did she come to complete her postgraduate studies and then became a professor and Head of the UFS Department of Business Management?


A matter of timing

Prof Brownhilder Neneh, Associate Professor in the Department of Business Management, tells the story. “It was a matter of timing. The new intake in the US took place in June; I started looking around and saw that there was an opportunity to come to the UFS. I did not want to waste six months; so, I came here, did my honours degree, and within one year and five months, I completed my master’s degree (Cum Laude), and then went home. I thought of doing my PhD in Germany but realised that the language might be a challenge; I came back and within a year and a few months, I completed my PhD.”

Listening to Prof Neneh relate the story, one might think she does nothing but study; although her academic workload is high, she finds the time to play with her 14-month-old baby every day. “When I arrive home and she sees me – that’s when my energy soars – and we start playing. Where possible, I take her to conferences with me. As a working mother, I understand the challenge of finding the balance, and my husband is great in supporting me.”


Finding the balance

Having risen to the position of professor, being happily married, and apparently having found the balance which many people seems to strive for their entire lives, I ask Prof Neneh what her recipe for success is. She doesn’t hesitate: “Success is tied to who you marry (if you get married), the company you keep, hard work, consistency, and always trying to be the best at what you do – and, oh yes, failure is part of success; it teaches you to be persistent and resilient. I also believe that God’s grace and favour has added to my success.” At a conference in September 2019, Prof Neneh once again talked about her favourite topic – women entrepreneurs and the challenges they face. She believes that there is a lot to be done to lessen the load of entrepreneurial women. And as I get ready to leave, I ask for her definition of success. She doesn’t hesitate: “Seeing students fly above you – and shining. Yes, to see them shine.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept